^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

COMPANY:
NVIGEN

i
Other names: NVIGEN | NVIGEN, Inc. | NVIGEN, Inc | NVIGEN Inc. | NVIGEN Inc | Nvigen | NVIGEN INC. | NVIGEN INC | NVIGEN, INC. | NVIGEN, INC
Related tests:
Evidence

News

2ms
NVIGEN pioneers breakthrough in high-resolution tissue RNA sequencing with magnetic nanoparticle capture from nanopipetting aspiration of minuscule single cell contents (NVIGEN Press Release)
"NVIGEN...announces its new application in RNA sequencing (RNAseq) that promises to transform our understanding of cellular dynamics within tissues...NVIGEN’s magnetic nanoparticle capture is poised to usher in a new era in tissue RNAseq. One of the most remarkable features of this approach is the ability to provide not only spatial but also temporal resolution. Researchers can now sample individual cells multiple times, capturing longitudinal information that was previously unattainable."
Clinical
almost1year
NVIGEN unveils groundbreaking comprehensive liquid biopsy at San Antonio Breast Cancer Symposium: Advancing clinical utility with multimodal biomarker detection enabled by highly versatile nanoparticle capture (PRNewswire)
"NVIGEN...unveil its groundbreaking technology, NVIGEN X®-Precision Medicine Biomarker Profiling, at the San Antonio Breast Cancer Symposium from December 5 to 9."
Clinical data
|
NVIGEN X™
almost3years
Nvigen circulating tumor DNA assay shows high NGS data efficiency in quality control study (Genomeweb)
"Nvigen...presented data last week at the San Antonio Breast Cancer Symposium showing that its Nvigen X Cancer Precision Profiling assay accurately monitors dynamic changes in circulating tumor DNA, or ctDNA...In a poster presented at SABCS, Nvigen showed performance metrics data of Nvigen X and a case study from an ongoing 150-person pilot study of the assay's performance in breast cancer patients."
Clinical data
|
NVIGEN X™